astrazeneca oral glp 1 AstraZeneca's GLP-1 scored phase 2 wins, but no data yet AstraZeneca to advance in-licensed oral
Description
A Crowded Pipeline Means Strategic Differentiation Is Critical With over 100 assets in clinical development, ranging from multi-agonists like retatrutide (with potential for ~25% weight loss) to oral small molecules like orforglipron , the battle for clinical and commercial leadership will be intense [3]
Who Is This Drug Best For
ProFound Therapeutics ProFound Therapeutics is leveraging previously undiscovered human proteins to develop treatments for a wide range of diseases
The effects of glucose levels on the secretion of insulin and glucagon can be managed by glucagon-like peptide-1 (GLP-1) analogs
